> Skip repeated content

Biosimilar Barriers Persist Despite Billions in Potential Cost Savings: Who is Benefitting?

Healio Rheumatology—July 16, 2018

Healio Rheumatology featured HSS rheumatologist Allan Gibofsky, MD, in an article about access to biosimilars for patients.

"It is a major concern that the potential benefits of biosimilar medications have not been trickling down to patients," said Dr. Gibofsky.

"The best way to pass the savings to the patient is to reduce the administrative hurdles for physicians," he advised.

According to Dr. Gibofsky, prescribers need to make patients aware of where costs are being saved.

Read the full article at healio.com [registration required].

 

Need Help Finding a Physician?

Call us toll-free at:
+1.877.606.1555

Conditions & Treatments

adult child
Select A Body Part
Conditions: Adult head Conditions: Adult spine Conditions: Adult shoulder Conditions: Adult elbow Conditions: Adult hand Conditions: Adult hip Conditions: Adult knee Conditions: Adult ankle Conditions: Adult head Conditions: Adult full body Conditions: Child spine Conditions: Child elbow Conditions: Child hip Conditions: Child hand Conditions: Child knee Conditions: Child ankle Conditions: Child full body


Conditions A-Z
A B C D E F G H I
J K L M N O P Q R
S T U V W X Y Z
SEE ALL

Media Contacts

Tracy Hickenbottom
Monique Irons
Sherry Randolph

212.606.1197
mediarelations@hss.edu

Social Media Contacts